MannKind Corporation (NASDAQ:MNKD) reported financial results for the first quarter ended March 31, 2015. For the first quarter of 2015, total operating expenses were …
MannKind Corporation (NASDAQ:MNKD) announced that it will begin to manufacture a 12 unit cartridge strength of AFREZZA (insulin human) Inhalation Powder to improve …
MannKind Corporation (NASDAQ:MNKD) announced its fourth quarter fiscal 2014 earnings report on Wednesday, February 24th with results generally in line with expectations. Highlights from the …
J.P.
MLV’s healthcare analyst Arlinda Lee weighed in today with a few insights on MannKind Corporation (NASDAQ:MNKD), after the company reported its fourth-quarter results, posting EPS of …
In a research report published Wednesday, Piper Jaffray analyst Joshua Schimmer reiterated a Neutral rating on MannKind Corporation (NASDAQ:MNKD) with a $7 price target, following …
MannKind Corporation (NADSAQ:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2014. For the fourth quarter, our …
In a research report published Friday, MLV analyst Arlinda Lee reiterated a Hold rating on MannKind Corporation (NASDAQ:MNKD) with a price target of …
In a research report published today, MLV analyst Arlinda Lee maintained a Hold rating on MannKind Corporation (NASDAQ:MNKD), while reducing her price target to $7 …